Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Efficacy of Almonds Added to Chronic Statin Therapy [Phase 4]
This Phase 4 trial assessed whether adding almond consumption to ongoing statin therapy improves lipid outcomes in people with hyperlipidemi…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress [Phase 2, Phase 3]
Phase 2/3 trial evaluating pterostilbene effects on cholesterol, blood pressure, and oxidative stress; study completed with results posted i…
-
CLINICAL_TRIALS research · 2013-04-30Clinical Trial Update: The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia [Phase 3]
A Phase 3 clinical trial evaluating green tea extract for people with type 2 diabetes and hyperlipidemia has completed.
-
FDA approval · 2013-04-29FDA Approved: LOVASTATIN — Supplemental Application (Carlsbad Technology, Inc.)
FDA approved a supplemental application for Lovastatin submitted by Carlsbad Technology, Inc. under ANDA 075991.
-
FDA approval · 2013-04-22FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-04-18FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for Pravastatin Sodium from Lupin Pharmaceuticals (ANDA 077917), formalizing approval of this generi…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects [Phase 2]
Phase 2 safety and efficacy results for mipomersen in high-risk statin-intolerant patients. Results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated the weight and metabolic effects of an almond-enriched, hypocaloric, low-fat diet in overweight and obe…
-
FDA approval · 2013-03-26FDA Approved: FLUVASTATIN SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Fluvastatin Sodium (generic Fluvastatin) from Mylan Pharmaceuticals Inc. (ANDA 090595), enabling…
-
CLINICAL_TRIALS withdrawal · 2013-03-22Clinical Trial Update: Garlic in Hyperlipidemia Caused by HAART [Phase 2]
This update indicates a Phase 2 trial evaluating garlic for HAART-induced hyperlipidemia in people with HIV has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy [NA]
This clinical trial update reports on erythrocyte-bound apolipoprotein B after withdrawal of statin therapy in participants with hyperlipide…
-
FDA approval · 2013-03-07FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) filed by Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects [Phase 1]
This Phase 1 pharmacokinetics study evaluated potential drug interactions of the HL-040XC fixed-dose combination tablet in healthy male subj…
-
CLINICAL_TRIALS research · 2013-03-07Clinical Trial Update: Nutraceuticals to Improve Lipid Profile in European Countries [Phase 4]
Phase 4 clinical trial evaluating nutraceuticals to improve lipid profiles in European countries for hyperlipidemia. The current status of t…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Combined Effects of Bioactive Compounds in Lipid Profile [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the combined effects of bioactive compounds on lipid levels in individuals with hyperlipidemia and ele…
-
FDA approval · 2013-02-27FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2013-02-25FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS [Phase 2]
A Phase 2 clinical trial evaluating low doses of AEGR-733 for reducing hepatic fat accumulation in patients with hyperlipidemia; the study i…
-
FDA approval · 2013-02-15FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) by Cosette Pharmaceuticals, Inc., updating its labeling …
-
CLINICAL_TRIALS research · 2013-02-08Clinical Trial Update: Diurnal Triglyceridemia in Relation to Alcohol Intake
This completed clinical trial assessed diurnal triglyceride variation in relation to alcohol intake in adults, including individuals with hy…
-
FDA approval · 2013-02-05FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for pravastatin sodium from Aurobindo Pharma Limited, granting approval for a generic pravastatin so…
-
FDA approval · 2013-02-05FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA issued an approval of a supplemental application for pravastatin sodium from Teva Pharmaceuticals USA, Inc. The action indicates a modif…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Nicotinic Acid Composition of HDL and Arterial Endothelium Function in Premature Coronary Heart Disease and High HDL [Phase 4]
Phase 4 trial evaluating how nicotinic acid affects HDL composition and arterial endothelial function in individuals with dyslipidemia and p…
-
FDA approval · 2013-01-28FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for fenofibric acid submitted by Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2013-01-27FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries Inc.)
The FDA approved a supplemental application for atorvastatin calcium submitted by Sun Pharmaceutical Industries Inc.